deltatrials
Completed OBSERVATIONAL NCT05448248

Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH)

A Registry Study of Cerebral Venous Sinus Thrombosis in China

Sponsor: Brain Hospital of Hunan Provincial

Updated 6 times since 2022 Last updated: Feb 23, 2024 Started: Aug 20, 2022 Primary completion: Dec 20, 2023 Completion: Dec 20, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05448248, this observational or N/A phase trial focuses on Cerebral Vein Thrombosis and Cerebral Venous Sinus Thrombosis and remains completed. Sponsored by Brain Hospital of Hunan Provincial, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshot~Dec 2022 – ~Mar 2023 · 3 months · monthly snapshot~Mar 2023 – ~Mar 2024 · 12 months · monthly snapshotRecruiting~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Mar 2024 — Jul 2024 [monthly]

    Completed

    Status: RecruitingCompleted

  4. Mar 2023 — Mar 2024 [monthly]

    Recruiting

  5. Dec 2022 — Mar 2023 [monthly]

    Recruiting

Show 1 earlier version
  1. Sep 2022 — Dec 2022 [monthly]

    Recruiting

    First recorded

Aug 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Brain Hospital of Hunan Provincial
  • Capital Medical University
  • Guizhou Provincial People's Hospital
  • The Affiliated Hospital of Xuzhou Medical University
  • The First Affiliated Hospital of Zhengzhou University
Data source: Capital Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations